Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.
about
Human Serum Eye Drops in Eye Alterations: An Insight and a Critical AnalysisComparison of corneal biomechanics in Sjögren's syndrome and non-Sjögren's syndrome dry eyes by Scheimpflug based device.Effect of mesenchymal stem cells on Sjögren-like mice and the microRNA expression profiles of splenic CD4+ T cellsActivation of Dll4/Notch Signaling and Hypoxia-Inducible Factor-1 Alpha Facilitates Lymphangiogenesis in Lacrimal Glands in Dry EyeTopical administration of Esculetin as a potential therapy for experimental dry eye syndrome.The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy StudyInterferon-γ-Induced Unfolded Protein Response in Conjunctival Goblet Cells as a Cause of Mucin Deficiency in Sjögren Syndrome.Severity of dry eye syndrome is related to anti-dsDNA autoantibody in systemic lupus erythematosus patients without secondary Sjogren syndrome: A cross-sectional analysis.Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease.Ocular Toxicity of Tyrosine Kinase Inhibitors.Meibomian gland dysfunction patients with novel Sjögren's syndrome biomarkers benefit significantly from a single vectored thermal pulsation procedure: a retrospective analysis.Topical administration of Metamizole and its implications on vascular reactivity in Wistar rats- Experimental research.Evaluation of a novel dry eye model induced by oral administration of finasteride.Alteration in nerves and neurotransmitter stimulation of lacrimal gland secretion in the TSP-1-/- mouse model of aqueous deficiency dry eye.Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye DiseaseConjunctival Inflammatory Gene Expression Profiling in Dry Eye Disease: Correlations With HLA-DRA and HLA-DRB1
P2860
Q26778628-0A5AACF1-0B13-488C-BAAD-865391B22A59Q33706060-30FF0823-11F1-42D4-BD07-DAC50EF6E76FQ33744508-C480D7D1-4345-45B6-B43C-95BC04A884F0Q35909290-AAC4A9DD-5190-4BDB-9AE3-4A05A88A7BABQ36413214-C9F4448A-732D-4166-AD44-B6C7E4964D29Q36864045-BA17EB42-F462-4445-9F86-DCE1AA145F76Q36990222-CCC485A9-0B2F-42D3-9CBF-35EA7808C36BQ37116902-F3398075-6875-492D-879D-2A8BB90DAA20Q37721598-E8CA80C3-4479-4E8B-B0C0-71B25CB96604Q38746683-AA4121B3-B9C0-4F87-BE37-3A89C89C2911Q38811692-C7FA8635-845A-435E-BDA1-3E0BDAD00113Q47161432-3DECE096-63EE-4B22-A554-4F51F88489F6Q47778585-2F264BA4-0F83-443C-A5FE-475801028877Q52688453-78E656C9-3DBE-4A75-A8EF-C0BDF9EFF773Q57479273-B412C837-FC07-4A85-867B-389D43AF64F8Q58122088-311D7A0C-303B-44A6-B765-4908D75C260D
P2860
Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Managing Sjögren's Syndrome an ...... ith anti-inflammatory therapy.
@ast
Managing Sjögren's Syndrome an ...... ith anti-inflammatory therapy.
@en
Managing Sjögren's Syndrome an ...... ith anti-inflammatory therapy.
@nl
type
label
Managing Sjögren's Syndrome an ...... ith anti-inflammatory therapy.
@ast
Managing Sjögren's Syndrome an ...... ith anti-inflammatory therapy.
@en
Managing Sjögren's Syndrome an ...... ith anti-inflammatory therapy.
@nl
prefLabel
Managing Sjögren's Syndrome an ...... ith anti-inflammatory therapy.
@ast
Managing Sjögren's Syndrome an ...... ith anti-inflammatory therapy.
@en
Managing Sjögren's Syndrome an ...... ith anti-inflammatory therapy.
@nl
P2860
P356
P1476
Managing Sjögren's Syndrome an ...... with anti-inflammatory therapy
@en
P2093
Terry G Coursey
P2860
P304
P356
10.2147/OPTH.S35685
P407
P577
2014-08-04T00:00:00Z